ELLINGTON MANAGEMENT GROUP LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 146 filers reported holding NEKTAR THERAPEUTICS in Q3 2014. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2017$1,164,000
+266.0%
49,600
+142.0%
0.04%
-61.9%
Q4 2014$318,000
-54.9%
20,500
-64.9%
0.10%
-78.3%
Q3 2014$705,000
+235.7%
58,400
+256.1%
0.48%
+393.9%
Q2 2014$210,000
-64.9%
16,400
-66.8%
0.10%
-44.0%
Q1 2014$599,00049,4000.18%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2014
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders